Janssen Vaccines & Prevention B.v.

Crucell Holland B.v.

Other

University of California

Gabriel Pascual

Robert Anthony Williamson

Jehangir Wadia

Elissa Keogh

Jaap Goudsmit

Katarina Radosevic

Johannes P M Langedijk

Angelique Van 't Wout

Johannes Petrus Langedijk

Michael G Rosenfeld

Christopher K Glass

The invention relates to antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau. The invention also relates to diagnostic, prophylactic and therapeutic methods using anti-tau antibodies.

Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau

The disclosure relates to antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau. The disclosure also relates to diagnostic, prophylactic and therapeutic methods using anti-tau antibodies.

Antibodies and antigen-binding fragments that specifically bind to  microtubule-associated protein tau

The disclosure relates to isolated antibodies and antigen-binding fragments that bind to the G protein of RSV and which are capable of neutralizing RSV A and B subtypes, and the use thereof in the diagnosis, prophylaxis, and/or treatment of RSV infections.

Human antibodies binding to RSV G protein

The disclosure provides isolated antibodies and antigen-binding fragments that bind to the G protein of RSV and which are capable of neutralizing RSV.

Human antibodies binding to RSV G proteins

Provided herein are antibodies or antigen-binding fragments thereof that immunospecifically bind to the fusion (F) protein of Respiratory Syncytial Virus (RSV). Also provided are methods for of prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of RSV-mediated disease. Methods of generating antibodies that immunospecifically bind RSV F protein also are provided.

Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use

Anti-human respiratory syncytial virus (RSV) antibodies and methods of use

Antibodies against human respiratory syncytial virus (RSV) and methods of use

The present invention relates to a method of screening for a compound that regulate SUMOylation of the nuclear receptor proteins comprising contacting the compound of interest to the nuclear receptor protein, and detecting SUMOylation of the nuclear receptor protein, thereby screening for a compound that regulates SUMOylation.

Identification of an evolutionarily conserved pathway mediating transrepression of inflammatory response genes by nuclear receptors

This taper gauge device is for barbers, stylists, beauticians, and the layman, and primarily, it consists of a body which is received on the cutting head of a hair clipper. It also includes teeth on its side walls and spaced ribs, for rolling movement on a person's hair, and openings are included in its side walls for receiving a pair of pins extending from the head of the hair clipper.

Growing community of inventors

San Diego, CA, United States of America

Gabriel Pascual